Cite
Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.
MLA
Dakappagari, N. K., et al. “Prevention of Mammary Tumors with a Chimeric HER-2 B-Cell Epitope Peptide Vaccine.” Cancer Research, vol. 60, no. 14, July 2000, pp. 3782–89. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10919651&authtype=sso&custid=ns315887.
APA
Dakappagari, N. K., Douglas, D. B., Triozzi, P. L., Stevens, V. C., & Kaumaya, P. T. (2000). Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine. Cancer Research, 60(14), 3782–3789.
Chicago
Dakappagari, N K, D B Douglas, P L Triozzi, V C Stevens, and P T Kaumaya. 2000. “Prevention of Mammary Tumors with a Chimeric HER-2 B-Cell Epitope Peptide Vaccine.” Cancer Research 60 (14): 3782–89. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10919651&authtype=sso&custid=ns315887.